home / stock / bayry / bayry articles

BAYRY Articles, Bayer AG ADR - From 12/06/23

Stock Information
Company Name: Bayer AG ADR
Stock Symbol: BAYRY
Market: OTC
Menu
BAYRY BAYRY Quote BAYRY Short BAYRY News BAYRY Articles BAYRY Message Board
Get BAYRY Alerts

News, Short Squeeze, Breakout and More Instantly...
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) encountered another setback in its ongoing legal battles related to its Roundup weedkiller after ...
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion | Benzinga

The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Ro...

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence | Benzinga

Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits | Benzinga

The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable f...

Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) CEO Bill Anderson announced plans to streamline its operations by cutting back on manag...
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) faces another legal setback as a California jury has ruled in favor of a plaintiff who claimed th...

From Years to Months: How AI is Shaping the Landscape of Clinical Trials | Benzinga

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially ...

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch | Benzinga

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several l...
Previous 10 Next 10